Pictet Asset Management (Switzerland)’s Sarepta Therapeutics SRPT Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio SRPT Stock Details SRPT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$109M	Sell
2023 Q1	$167M	Buy
2022 Q4	$121M	Buy
2022 Q3	$73.7M	Buy
2022 Q2	$8.93M	Buy
2022 Q1	$6.86M	Sell
2021 Q4	$8.3M	Buy
2021 Q3	$7.48M	Buy